BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.33), $0.30 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $25.42 million versus the consensus estimate of $23.71 million.

GUIDANCE:

BioLife Solutions sees FY2025 revenue of $100-103 million, versus the consensus of $97.76 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.